(Q40254574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Clelia Domenzáin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

María Jose Docampo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Rosa M Rabanal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Anna Bassols

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Montserrat Serra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Daniel Hernández

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Inés de Torres

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Thomas N Wight

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Angels Fabra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

17 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

889-901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16847433%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700449

27 December 2019

exact match

0 references

cites work

The interaction of versican with its binding partners

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Lecticans: organizers of the brain extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Versican: a versatile extracellular matrix proteoglycan in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Distinct interaction of versican/PG-M with hyaluronan and link protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Versican is differentially expressed in human melanoma and may play a role in tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Effect of transforming growth factor-beta1, insulin-like growth factor-I, and hepatocyte growth factor on proteoglycan production and regulation in canine melanoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Differential expression of versican isoforms is a component of the human melanoma cell differentiation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Tumor stroma and regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Cancer: the matrix is now in control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Tumor invasion: a consequence of destructive and compositional matrix alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Hyaluronan-cell interactions in cancer and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Hyaluronan and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Hyaluronan promotes the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Increased synthesis of hyaluronate enhances motility of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Versican protects cells from oxidative stress-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

7 January 2021

The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

7 January 2021

Versican/PG-M G3 domain promotes tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

7 January 2021

Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700449

7 January 2021